Imfinzi-Imjudo dual immunotherapy offers new option for 1st-line treatment of liver cancer < Pharma < Article
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have...
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have...
The Internet of Things (IoT) and neuroscience are two rapidly advancing fields that are transforming the healthcare industry. Combining these...
Metabolic diseases like obesity can increase the risk of developing liver cancer, research has shown. But how one disease predisposes...
Significant numbers of patients with dementia may have undiagnosed liver disease, and hepatic encephalopathy may be contributing to their cognitive...
Jake Algerio lives in Honesdale with his family. The 10-year-old is a fourth grader at Lakeside Elementary School who, like...
New Delhi: The Union health ministry said it has decided to offer neurological care at Ayushman Arogya Mandirs, the government's...